Monopar Therapeutics (MNPR) PT Raised to $105 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andres Y. Maldonado raised the price target on Monopar Therapeutics (NASDAQ: MNPR) to $105.00 (from $70.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
